frankly malignant angiosarcoma [1] . These tumors can occur in almost all locations but rarely involve the neuraxis. Three histologic subgroups including epithelioid, spindle cell and malignant endovascular HE have been defi ned [2] . The etiology is unknown, but it may be associated with vascular malformations involving other organs. It can also be associated with hemolytic anemia, thrombocytopenia and coagulopathy [3] .
Introduction

Hemangioendothelioma (HE) is a vascular neoplasm composed of endothelial cells and is considered to be of an intermediary pathology between hemangioma and 355
The patient then underwent a laminectomy from T 12 -L 1 . After removal of the overlying bone, the dura on the right-hand side was found to have a slightly bluish discoloration. The dura was tense with a fi rm mass palpable beneath the surface. Upon opening of the dura, a blue-black tumor was identifi ed with many vessels present on its surface. The tumor was attached to the fi lum terminale. A biopsy was taken and the tumor was found to be quite vascular and fi rm. After severing the fi lum and dissecting the surrounding roots from the tumor, dissection proceeded superiorly, separating the tumor from the pial surface of the spinal cord. Debulking of the tumor was accomplished by using an ultrasonic aspirator. Near the superior portion, the tumor was found to extend into the spinal cord. This intramedullary portion was carefully dissected from the spinal cord. The tumor was separable from the spinal cord in most places but there was no well-developed capsule. Using bipolar coagulation and ultrasonic aspirator, gross removal of all visible tumor was completed. Augmentation duroplasty was then performed with a dura graft and the wound was closed in layers.
The pathology specimen consisted of multiple fragments of soft hemorrhagic tissue measuring in aggregate approximately 2.0 ! 3.0 cm. This was fi xed in 10% buffered formalin. Histologic sections were stained with hematoxylin and eosin (HE) in the standard fashion, as well as with an extensive immunohistochemical panel.
Immunohistochemical stains included endothelial cell markers, factor VIII, CD34, CD31, vimentin, glial fi brillary acidic protein, The lesion consisted of a vascular tumor composed largely of an irregular aggregate of vascular spaces with an endothelial cell lining and an intervening population of similar endothelial cells ( fi g. 2 a). Vascular channels varied in caliber from very small capillary type vessels to larger more ectatic back-to-back vascular arrangements.
Varying degrees of intervening collagenous stromal fi brous tissue and focal area of myxoid stromal change were present. There was evidence of previous intratumoral hemorrhage with hemosiderin deposits. The endothelial cells ranged from bland to focally more plump, large and atypical forms that were polygonal to spindled. In areas, individual cells showed intracellular cytoplasmic vacuoles. Mitotic activity was not present. The immunohistochemical profi le confi rmed the endothelial and vascular nature of the lesion with both the intervening as well as vascular space lining cells showing positivity for the endothelial cell markers factor VIII, CD34, CD31 and vimentin ( fi g. 2 b). The cells were negative for keratin, NSE, S100, EMA, GFAP and synaptophysin. A diagnosis of hemangioendothelioma was made.
Postoperatively, the patient's urinary and bowel symptoms resolved but he continued to have mild perianal numbness and left hip fl exor weakness for which he used a cane. A postoperative MRI demonstrated a small enhancing nodular area at the right posterior conus at the T 12 level, measuring less than 1 cm in length ( fi g. 3 ). This was adjudged to represent residual disease on radiology review and radiotherapy was offered to improve local control. He received a total of 50.4 Gy in 28 fractions over 5.5 weeks (1.8 Gy per fraction). He was followed on a regular basis with clinical examination and MRI scans. The patient is doing well with no radiation toxicity and no residual disease on the MRI at 48 months' follow-up ( fi g. 4 ).
Discussion
HE is a neoplasm composed of endothelial cells, and is considered to represent a neoplasm of intermediate or borderline malignant potential [1] . More recently, histologic subtypes, including epithelioid, spindle cell and polymorphous forms, have been described [2] . The present case conforms best to the polymorphous subtype of HE demonstrating some variability in morphologic pattern with spindled cell areas, more polygonal epithelioid areas, as well as variable vascular density within the lesion.
The treatment of choice for spinal HE is complete excision of the tumor. Although radiation has been used as an adjuvant treatment, the role of irradiation has not been clearly defi ned. In 1980, Pearl et al. [4] treated a benign epidural HE at T 8 spine with surgery and postoperative radiotherapy (radiation = 30 Gy/10 fraction) with good results. Mahdavi et al. [5] reported an intradural-extramedullary lesion that recurred twice and was irradiated after the third resection. The fi rst local recurrence occurred 8 months after the fi rst operation. The second local recurrence happened at about 4 months from the second surgery. However, when radiotherapy was delivered postoperatively after the third resection, no disease was seen on MRI for 28 months. Unfortunately, it is unclear whether partial or gross total resection was performed. Ronca- pear to offer some advantage over surgery alone as it would seem to diminish the chances of recurrences in the operated cases [5, 11] . A recent report by Roncaroli et al. [6] suggested observation alone after surgery without adjuvant therapy, however, the follow-up period of 14 months in the reported case was comparatively short. The present case is similar to that reported by Abdullah et al. [11] where postoperative limited fi eld radiation was given although there was no interferon therapy offered to our patient after radiation. Similar to that report, our patient has no evidence of progression of disease at 48 months' follow-up. At this point, no radiation toxicity has been detected in our patient. In fact, there was no evidence of recurrent disease as reported in the most recent MRI.
Conclusion
The optimum treatment for HE has not been well established, maximal surgical resection probably remains the main modality of therapy. However, postoperative radiotherapy may play a role in the management of intraspinal HE especially in partially resected or recurrent cases.
roli et al. [6] recently reported a case of primary HE from the spinal cord that did not recur 14 months after a complete resection. Preoperative radiotherapy has been used to remove a huge tumor completely [7] .
In the pediatric population, there is an extensive experience with the use of interferon-alpha. It has been used in treating HE with good results [3] . Other chemotherapeutic agents have been used including ifosfamide, etoposide, platinum and cyclophosphamide with varying responses [8] [9] [10] .
The case presented in this report is unique in many aspects. Firstly, besides being a rare disease involving a rare site (spinal cord), the lesion was intradural with intramedullary extension. Previous case reports involve tumor in the intradural and extramedullary sites [5] . Apart from two reports [6, 11] , a literature review has failed to identify reports on primary spinal HE with intramedullary or partially intramedullary involvement as in the current case report. Secondly, postoperative radiotherapy was offered to the patient rather than observation. This decision was based on the documentation of residual disease and the higher risk of morbidity with repeated surgery in this patient. Although the role of radiotherapy in the management of spinal HE is still unclear, it would ap-
